Seeking Alpha

Jazz Pharmaceuticals (JAZZ +2.8%) posts another gain after Friday's big post-Q2 earnings report...

Jazz Pharmaceuticals (JAZZ +2.8%) posts another gain after Friday's big post-Q2 earnings report jump. Jefferies upgrades shares to a Buy from Hold with a $52 price target noting the firm "previously modeled only 5% volume growth in '11-'13," but now sees "double-digit growth."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)